| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |